# Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients

> **NCT06147154** · — · COMPLETED · sponsor: **Qilu Hospital of Shandong University** · enrollment: 23 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma (PDAC)

## Interventions

- **OTHER:** 16S rRNA amplicon sequencing and untargeted metabolomics

## Key facts

- **NCT ID:** NCT06147154
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06147154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06147154, "Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06147154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*